[1]
|
M. Gemmell, Z. Matyas, Z. Pawlowsky and E. J. L. Soulsby, “Guidelines for Surveillance and Control of Taeniasis/Cysticercosis, Vol. 83,” World Health Organization, Switzerland, 1983, p. 49.
|
[2]
|
G. Roman, J. Sotelo, O. Del Brutto, et al., “A Proposal to Declare Neurocysticercosis an International Reportable Disease,” Bulletin of the World Health Organization, Vol. 78, No. 3, 2000, pp. 399-406
|
[3]
|
K. Hutcheson III, M. Kalafian, I. Taylor, J. Sagel and B. Clyburn, “Neurocysticercosis,” Southern Medical Journal, Vol. 7, 2000, pp. 666-668.
|
[4]
|
M. T. Wallin and J. F. Kurtzke, “Neurocysticercosis in the United States: Review of an Important Emerging Infection,” Neurology, Vol. 63, No. 9, 2004, pp. 1559-1564. http://dx.doi.org/10.1212/01.WNL.0000142979.98182.FF
|
[5]
|
O. H. Del Brutto, J. Sotelo, “Neurocysticercosis: An Update,” Clinical Infectious Disease, Vol. 10, No. 6, 1988, pp. 1075-1087.
|
[6]
|
J. G. Burneo, I. Plener and H. H. Garcia, “Neurocysticercosis in a Patient in Canada,” CMAJ, Vol. 180, No. 6, 2009, pp. 639-642.
|
[7]
|
H. H. Garcia and O. H. Del Brutto “Neurocysticercosis: Updated Concepts about an Old Disease,” The Lancet Neurology, Vol. 4, No. 10, 2005, pp. 653-661. http://dx.doi.org/10.1016/S1474-4422(05)70194-0
|
[8]
|
J. A. Serpa, L. S. Yancey and A. C. White Jr., “Advances in the Diagnosis and Management of Neurocysticercosis,” Expert Review of Anti-infective Therapy, Vol. 4, No. 6, 2006, pp. 1051-1061. http://dx.doi.org/10.1586/14787210.4.6.1051
|
[9]
|
H. H. Garcia, R. Gilman, M. Martinez, et al., “Cysticercosis as a Major Cause of Epilepsy in Peru. The Cysticercosis Working Group in Peru (CWG),” Lancet, Vol. 341, No. 8839, 1993, pp. 197-200. http://dx.doi.org/10.1016/0140-6736(93)90064-N
|
[10]
|
O. H. Del Brutto, V. Rajshekhar, A. C. White Jr., et al., “Proposed Diagnostic Criteria for Neurocysticercosis,” Neurology, Vol. 57, No. 2, 2001, pp. 177-183. http://dx.doi.org/10.1212/WNL.57.2.177
|
[11]
|
J. A. Serpa, A. Moran, J. C. Goodman, T. P. Giordano, and A. C. White Jr, “Neurocysticercosis in the HIV Era: A Case Report and Review of the Literature,” American Journal of Tropical Medicine and Hygiene, Vol. 77, No. 1, 2007, pp. 113-117.
|
[12]
|
S. Remy, MSN, RN, CEN and Vineland, “A 44-Year-Old Man with Neurocysticercosis,” Journal of Emergency Nursing, Vol. 35, No. 4, 2009, pp. 348-349. http://dx.doi.org/10.1016/j.jen.2008.04.024
|
[13]
|
S. A. Cudlip, P. R. Wilkins and H. T. Marsh, “Endoscopic Removal of a Third Ventricular Cysticercal Cyst,” British Journal of Neurosurgery, Vol. 12, No. 5, 1998, pp. 452-454. http://dx.doi.org/10.1080/02688699844691
|
[14]
|
R. Kelley, D. H. Duong and G. E. Locke, “Characteristics of Ventricular Shunt Malfunctions among Patients with Neurocysticercosis,” Neurosurgery, Vol. 50, No. 4, 2002, pp. 757-762. http://dx.doi.org/10.1097/00006123-200204000-00014
|
[15]
|
M. Bergsneider, L. T. Holly, J. H. Lee, W. A. King and J. G. Frazee, “Endoscopic Management of Cysticercal cysts within the Lateral and Third Ventricles,” Journal of Neurosurgery, Vol. 92, No. 1, 2000, pp. 14-23. http://dx.doi.org/10.3171/jns.2000.92.1.0014
|
[16]
|
V. Kalra, D. Mishra, A.Suri, R. Seth and A. Garg, “Intraventricular Neurocysticercosis,” The Indian Journal of Pediatrics, Vol. 76, No. 4, 2009, pp. 420-423.
|
[17]
|
H. H. García, C. A. Evans, T. E. Nash, O. M. Takayanagui, A. C. White, D. Botero, V. Rajshekhar, V. C.Tsang, et al., “Current Consensus Guidelines for Treatment of Neurocysticercosis,” Clinical Microbiology Reviews, Vol. 15, No. 4, 2002, pp. 747-756. http://dx.doi.org/10.1128/CMR.15.4.747-756.2002
|
[18]
|
A. Escobar and K. M. Weidenheim, “The Pathology of Neurocysticercosis,” In: G. Singh and S. Prabhakar, Eds., Taenia solium Cysticercosis: From Basic to Clinical Science, United Kingdom CABI Publishing, Wallingford, 2002, pp. 289-305. http://dx.doi.org/10.1079/9780851996288.0289
|
[19]
|
A. C. White Jr., “Neurocysticercosis: Updates on Epidemiology, Pathogenesis, Diagnosis, and Management,” Annual Review of Medicine, Vol. 51, 2000, pp. 187-206. http://dx.doi.org/10.1146/annurev.med.51.1.187
|
[20]
|
A. Carpio, “Neurocysticercosis: An Update,” The Lancet Infectious Diseases, Vol. 2, No. 12, 2002, pp. 751-762. http://dx.doi.org/10.1016/S1473-3099(02)00454-1
|
[21]
|
M. P. Earnest, L. B. Reller, C. M. Filley and A. J. Grek, “Neurocysticercosis in the United States: 35 Cases and a Review,” Reviews of Infectious Diseases, Vol. 9, No. 5, 1987, pp. 961-979. http://dx.doi.org/10.1093/clinids/9.5.961
|
[22]
|
J. E. Pittella, “Neurocysticercosis,” Brain Pathology, Vol. 7, No. 1, 1997, pp. 681-693. http://dx.doi.org/10.1111/j.1750-3639.1997.tb01083.x
|
[23]
|
H. H. García, A. E. Gonzalez, C. A. Evans and R. H. Gilman, “Cysticercosis Working Group in Peru. Taenia solium Cysticercosis,” Lancet, Vol. 362, No. 9383, 2003, pp. 547-556. http://dx.doi.org/10.1016/S0140-6736(03)14117-7
|
[24]
|
C. M. DeGiorgio, M. T. Medina, R. Durón , C. Zee and S. P. Escueta, “Neurocysticercosis,” Epilepsy Currents, Vol. 4, No. 3, 2004, pp. 107-111. http://dx.doi.org/10.1111/j.1535-7597.2004.43008.x
|
[25]
|
D. Scharf, “Neurocysticercosis: Two Hundred Thirty-Eight Cases from a California Hospital,” Archives of Neurology, Vol. 45, No. 7, 1988, pp. 777-780. http://dx.doi.org/10.1001/archneur.1988.00520310087022
|